Home » Oxycodone Shortage Prompted by GMP-Related Recalls
Oxycodone Shortage Prompted by GMP-Related Recalls
Large-scale recalls and a production stoppage by two major manufacturers has created a shortage of oxycodone immediate-release tablets, a potent opioid painkiller.
Mallinckrodt, Xanodyne Pharmaceuticals and Vintage Pharmaceuticals have short supplies of the product due to recalls by other drugmakers, according to the FDA’s drug shortage website.
The American Society of Health-System Pharmacists website lists manufacturing issues at KV Pharmaceutical and Actavis as the reason for the shortage. KV has halted production of all drug tablets.
Drug GMP Report
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May